UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Non-Canonical Cell Death Induced by p53

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2068-2068

2016

Volltextzugriff (PDF)

Targeting Oncogenic Mutant p53 for Cancer Therapy

Frontiers in oncology, 2015-12, Vol.5, p.288-288

2015

Volltextzugriff (PDF)

Regulators of Oncogenic Mutant TP53 Gain of Function

Cancers, 2018-12, Vol.11 (1), p.4

2018

Volltextzugriff (PDF)

p53 as a Regulator of Lipid Metabolism in Cancer

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2074-2074

2016

Volltextzugriff (PDF)

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials

Cancers, 2023-01, Vol.15 (2), p.429

2023

Volltextzugriff (PDF)

The interplay between mutant p53 and the mevalonate pathway

Cell death and differentiation, 2018-03, Vol.25 (3), p.460-470

2018

Volltextzugriff (PDF)

Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13527

2021

Volltextzugriff (PDF)

Suppressing STAT5 signaling affects osteosarcoma growth and stemness

Cell death & disease, 2020-02, Vol.11 (2), p.149-149, Article 149

2020

Volltextzugriff (PDF)

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway

Nature cell biology, 2016-11, Vol.18 (11), p.1233

2016

Volltextzugriff (PDF)

Emerging Non-Canonical Functions and Regulation of p53

International journal of molecular sciences, 2018-03, Vol.19 (4), p.1015

2018

Volltextzugriff (PDF)

MDM2, An Introduction

Molecular cancer research, 2003-12, Vol.1 (14), p.993-1000

2003

Volltextzugriff (PDF)

DNAJA1 promotes cancer metastasis through interaction with mutant p53

Oncogene, 2021-08, Vol.40 (31), p.5013-5025

2021

Volltextzugriff (PDF)

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

Proceedings of the National Academy of Sciences - PNAS, 2011-07, Vol.108 (29), p.11995-12000

2011

Volltextzugriff (PDF)

Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5

British journal of cancer, 2021-01, Vol.124 (1), p.166-175

2021

Volltextzugriff (PDF)

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Cell, 2004-12, Vol.119 (6), p.861-872

2004

Volltextzugriff (PDF)

Impacts of Heat Shock Protein 40/J-domain Proteins on Cancer Progression and p53 Activity

Thermal Medicine, 2022/07/01, Vol.38(2), pp.33-50

2022

Volltextzugriff (PDF)

A modified nucleoside O6-methyl-2'-deoxyguanosine-5'-triphosphate exhibits anti-glioblastoma activity in a caspase-independent manner

Pharmacological research, 2024-01, Vol.199, p.106990-106990, Article 106990

2024

Volltextzugriff (PDF)

Characterization of an Mtbp Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model

Cancers, 2023-09, Vol.15 (18), p.4596

2023

Volltextzugriff (PDF)

Abstract 5296: DNAJA1 promotes cancer progression by stabilizing mutant p53

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.5296-5296

Iwakuma, Tomoo

2019

Volltextzugriff (PDF)

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression

Nature communications, 2016-11, Vol.7 (1), p.13561-13561, Article 13561

2016

Volltextzugriff (PDF)

Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin

Cancers, 2022-08, Vol.14 (17), p.4187

2022

Volltextzugriff (PDF)

Comparative oncology approach to drug repurposing in osteosarcoma

PloS one, 2018-03, Vol.13 (3), p.e0194224

2018

Volltextzugriff (PDF)

A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development

Cancer cell, 2010-09, Vol.18 (3), p.220-230

2010

Volltextzugriff (PDF)

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome‐wide shRNA screen

International journal of cancer, 2016-08, Vol.139 (3), p.628-638

2016

Volltextzugriff (PDF)

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma

PloS one, 2017-06, Vol.12 (6), p.e0179168

2017

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(115)

Sprache

Englisch
(114)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(60)
Animals
(46)
Humans
(46)
Mice
(37)
Oncology
(29)
Cell Biology
(23)
Tumor Suppressor Protein P53 - Metabolism
(23)
Cancer
(20)
Metastasis
(20)
Biochemistry & Molecular Biology
(19)
Tumors
(18)
Cell Line, Tumor
(17)
Proteins
(16)
Tumor Suppressor Protein P53 - Genetics
(15)
Male
(14)
Mutation
(14)
Cell Cycle
(13)
Apoptosis
(12)
Female
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(21)
The Faseb Journal
(7)
Cancers
(6)
Oncogene
(5)
International Journal Of Molecular Sciences
(4)
Carcinogenesis
(3)
Cell Cycle
(3)
Genes & Development
(3)
Plos One
(3)
The Journal Of Clinical Investigation
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Non-Canonical Cell Death Induced by p53

Targeting Oncogenic Mutant p53 for Cancer Therapy

Regulators of Oncogenic Mutant TP53 Gain of Function

p53 as a Regulator of Lipid Metabolism in Cancer

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials

The interplay between mutant p53 and the mevalonate pathway

Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members

Suppressing STAT5 signaling affects osteosarcoma growth and stemness

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway

Emerging Non-Canonical Functions and Regulation of p53

MDM2, An Introduction

DNAJA1 promotes cancer metastasis through interaction with mutant p53

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Impacts of Heat Shock Protein 40/J-domain Proteins on Cancer Progression and p53 Activity

A modified nucleoside O6-methyl-2'-deoxyguanosine-5'-triphosphate exhibits anti-glioblastoma activity in a caspase-independent manner

Characterization of an Mtbp Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model

Abstract 5296: DNAJA1 promotes cancer progression by stabilizing mutant p53

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression

Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin

Comparative oncology approach to drug repurposing in osteosarcoma

A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome‐wide shRNA screen

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma

Suchergebnisse filtern